USA flag logo/image

An Official Website of the United States Government

LIQUID-GUIDED ACOUSTIC WAVE IMMUNOSENSOR

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
11072
Program Year/Program:
1989 / SBIR
Agency Tracking Number:
11072
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIODE, INC.
2 OAKWOOD RD CAPE ELIZABETH, ME 04107
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1989
Title: LIQUID-GUIDED ACOUSTIC WAVE IMMUNOSENSOR
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

BIODE, INC., WILL UTILIZE THE RESULTS OF ITS PHASE I RESEARCH TO DEVELOP A TOTALLY NEW SOLID-STATE BIOSENSOR TECHNOLOGY FOR BIOLOGICAL MEASUREMENTS. THIS TECHNOLOGY IS BASED UPON THE MERGING OF TWO OTHER RELATIVELY NEW TECHNOLOGIES, MONOCLONAL ANTIBODIES (HYBRIDOMA TECHNOLOGY) WITH ACOUSTIC WAVE MICROSENSORS. BY COMBINING THE SENSITIVITY OF ACOUSTIC WAVE SENSORS WITH THE SPECIFICITY OFANTIBODIES, BIODE, INC., WILL CREATE A NOVEL DETECTION TECHNOLOGY WITH THE POTENTIAL TO OVERCOME THE DRAWBACKS OF EXISTING IMMUNOASSAY TECHNOLOGY. THIS NEW IMMUNOSENSOR WILLOPERATE IN A CONTINUOUS AND THEREFORE HOMOGENEOUS MODE, YET IT IS EXPECTED TO EQUAL OR EXCEED THE SENSITIVITY LIMITS OF EXISTING HETEROGENEOUS IMMUNOASSAYS. AN ACOUSTIC WAVE MICROSENSOR BASED UPON THE PRINCIPLE OF LIQUID-GUIDED ACOUSTIC WAVE (LGAW) TECHNOLOGY WILL BE TESTED. THE IMMUNOSENSOR TECHNOLOGY WILL ALLOW FOR HOMOGENEOUS ASSAYS THAT MEET OR EXCEED THE PRESENT STATE-OF-THE-ART HETEROGENEOUS ASSAYS. AS THE LGAW IMMUNOSENSOR TECHNOLOGY PROPOSED BY BIODE, INC., DOES NOT NOW EXIST, IT REPRESENTS A TRUE TECHNOLOGICAL INNOVATION SHOULD THE FEASIBILITY RESULTS OF PHASE I RESEARCH PROVE FRUITFUL.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

Biode Inc
2 Oakwood Rd Cape Elizabeth, ME 04107

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No